azacitidine significantly improved overall survival in patients ineligible for intensive chemotherapy, a patient population who typically have a five-year overall survival rate of less than 10%
1
Venclyxto
-based combinations to provide clinically meaningful benefits in difficult to treat blood cancers
Basel, 25 May 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the European Commission has approved Venclyxto® (venetoclax) in combination with hypomethylating agents, azacitidine and decitabine, for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (AML) who are ineligible for intensive chemotherapy.
“This Venclyxto approval is a critical step in providing new therapeutic options for patients in the EU newly diagnosed with AML who cannot tolerate the side effects of, or are ineligible for, intensive chemotherapy,” said Levi Garraway, M.D., Ph.D., Roche’s Chief Medical Officer and Head of Global Product Development. “Venclyxto-ba
Delhi High Court Seeks Centre s Response On How It Intends To Obtain Supply Of Tocilizumab Drug livelaw.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from livelaw.in Daily Mail and Mail on Sunday newspapers.
Search jobs Dercum’s Disease Treatment Market Size, Research Findings and Conclusion Forecast 2028
DBMR has added a new report titled Dercum’s Disease Treatment Market with analysis that provides the insights which bring marketplace clearly into the focus and thus help organizations make better decisions. The data and the information regarding the industry are taken from consistent sources such as websites, annual reports of the companies, and journals which are then checked and validated by the market experts. Dercum’s Disease Treatment Market report has been structured with transparent research studies which makes it of supreme quality. By exactly understanding customer requirement, one or more methods are used to construct this finest market research report. The report provides with CAGR value fluctuation during the forecast period of 2021 – 2028 for the market.
View our Exclusive report on Market scenarios, Estimates, the impact of lockdown, and Customer Behaviour.
Technavio has announced its latest market research report titled Coronavirus Test Kits Market in North America by End-user and Geography - Forecast and Analysis 2021-2025
The report on the Coronavirus test kits market in North America provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis.
In addition, the report also provides an up-to-date analysis regarding the current global market scenario and overall market environment. The market is driven by the regional outbreak of coronavirus and product innovations
New Trends in Obesity Management Market Size 2021
Search jobs New Trends in Obesity Management Market Size 2021
High costs involved in the research & development (R&D) of obesity drugs, coupled with limited financial support, are collectively a great challenge for adoption of obesity management solutions. Additionally, long gestation time needed for R&D activities, and the inclusion of clinical trials required to test these drugs hikes the expenditure significantly. Considering this scenario, manufacturers are being cautious while seeking better return on investments. In the long run, risks and limitations posed by the high development costs of obesity drugs are likely to impede the growth of the global obesity management market.